Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists.
- Published In:
- Journal of neurogastroenterology and motility, 23(2), 171-179 (2017)
- Authors:
- Mosińska, Paula, Zatorski, Hubert, Storr, Martin, Fichna, Jakub
- Database ID:
- RPEP-03405
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03405APA
Mosińska, Paula; Zatorski, Hubert; Storr, Martin; Fichna, Jakub. (2017). Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists.. Journal of neurogastroenterology and motility, 23(2), 171-179. https://doi.org/10.5056/jnm16183
MLA
Mosińska, Paula, et al. "Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists.." Journal of neurogastroenterology and motility, 2017. https://doi.org/10.5056/jnm16183
RethinkPeptides
RethinkPeptides Research Database. "Future Treatment of Constipation-associated Disorders: Role ..." RPEP-03405. Retrieved from https://rethinkpeptides.com/research/mosinska-2017-future-treatment-of-constipationassociated
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.